Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 16, Issue 14
|
pp. 11275–11288
Interference with ANXA8 inhibits the malignant progression of ovarian cancer by suppressing the activation of the Wnt/β-catenin signaling pathway via UCHL5
Back to article
Figure 7
(7 of 8)
−
100%
+
Figure 7.
Interference with ANXA8 inhibited the activation of Wnt/β-catenin signaling pathway via UCHL5.
Western blot analysis of Wnt/β-catenin signaling pathway-related proteins. ***P<0.001 vs. control; ##P<0.01, ###P<0.001 vs. shRNA-ANXA8+Ov-NC.